ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $205,000 | +19.2% | 22,300 | 0.0% | 0.00% | – |
| Q4 2016 | $172,000 | -32.5% | 22,300 | 0.0% | 0.00% | – |
| Q3 2016 | $255,000 | +22.6% | 22,300 | +32.0% | 0.00% | – |
| Q2 2016 | $208,000 | -19.1% | 16,900 | +48.2% | 0.00% | – |
| Q4 2015 | $257,000 | +21.2% | 11,400 | -10.9% | 0.00% | – |
| Q3 2015 | $212,000 | -26.4% | 12,800 | 0.0% | 0.00% | – |
| Q2 2015 | $288,000 | +25.8% | 12,800 | +43.8% | 0.00% | – |
| Q1 2015 | $229,000 | +102.7% | 8,900 | +71.2% | 0.00% | – |
| Q4 2014 | $113,000 | -9.6% | 5,200 | -21.2% | 0.00% | – |
| Q3 2014 | $125,000 | -17.2% | 6,600 | +1.5% | 0.00% | – |
| Q2 2014 | $151,000 | +202.0% | 6,500 | +341.3% | 0.00% | – |
| Q1 2014 | $50,000 | +2400.0% | 1,473 | +1917.8% | 0.00% | – |
| Q4 2013 | $2,000 | +100.0% | 73 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |